UK's National Institute for Health and Care Excellence has recommended Genomic Health's Oncotype DX as a tool to help doctors decide whether a woman with a specific type of breast cancer should be treated with chemotherapy.
UK's National Institute for Health and Care Excellence has recommended Genomic Health's Oncotype DX as a tool to help doctors decide whether a woman with a specific type of breast cancer should be treated with chemotherapy.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.